BWM
ABBV icon

BerganKDV Wealth Management’s AbbVie ABBV Stock Holding History

BerganKDV Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.84M Buy
13,689
+177
+1% +$26K 0.18% 94
2023
Q1 		$2.15M Buy
13,512
+142
+1% +$21.7K 0.22% 79
2022
Q4 		$2.16M Buy
13,370
+183
+1% +$28.1K 0.23% 80
2022
Q3 		$1.77M Buy
13,187
+215
+2% +$30.9K 0.21% 89
2022
Q2 		$1.99M Buy
12,972
+3
+0% +$458 0.23% 90
2022
Q1 		$2.1M Buy
12,969
+7
+0.1% +$1.02K 0.22% 90
2021
Q4 		$1.75M Buy
12,962
+112
+0.9% +$13.2K 0.18% 99
2021
Q3 		$1.39M Buy
12,850
+876
+7% +$100K 0.16% 108
2021
Q2 		$1.35M Buy
11,974
+3
+0% +$338 0.16% 107
2021
Q1 		$1.29M Sell
11,971
-8
-0.1% -$856 0.17% 106
2020
Q4 		$1.28M Buy
11,979
+36
+0.3% +$3.46K 0.18% 98
2020
Q3 		$1.05M Buy
11,943
+3
+0% +$282 0.17% 97
2020
Q2 		$1.17M Sell
11,940
-285
-2% -$25.1K 0.2% 93
2020
Q1 		$931K Sell
12,225
-1,028
-8% -$87.6K 0.19% 92
2019
Q4 		$1.17M Sell
13,253
-17,971
-58% -$1.49M 0.21% 96
2019
Q3 		$2.36M Sell
31,224
-509
-2% -$34.9K 0.47% 46
2019
Q2 		$2.31M Buy
31,733
+6,164
+24% +$484K 0.46% 47
2019
Q1 		$2.06M Buy
25,569
+3,400
+15% +$278K 0.42% 52
2018
Q4 		$2.04M Sell
22,169
-703
-3% -$61.8K 0.48% 36
2018
Q3 		$2.16M Buy
22,872
+319
+1% +$30.3K 0.47% 37
2018
Q2 		$2.09M Sell
22,553
-770
-3% -$75.2K 0.47% 34
2018
Q1 		$2.21M Sell
23,323
-257
-1% -$28.2K 0.6% 27
2017
Q4 		$2.28M Sell
23,580
-2,146
-8% -$202K 0.54% 28
2017
Q3 		$2.29M Sell
25,726
-1,355
-5% -$103K 0.57% 25
2017
Q2 		$1.96M Buy
27,081
+719
+3% +$48.3K 0.56% 23
2017
Q1 		$1.72M Buy
26,362
+2,262
+9% +$142K 0.51% 28
2016
Q4 		$1.51M Sell
24,100
-1,073
-4% -$65.5K 0.5% 35
2016
Q3 		$1.59M Sell
25,173
-1,693
-6% -$110K 0.55% 28
2016
Q2 		$1.66M Buy
26,866
+6,162
+30% +$375K 0.71% 30
2016
Q1 		$1.18M Buy
+20,704
New +$1.15M 0.71% 40

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BerganKDV Wealth Management's ABBV Position: Q2 2023 in Review

BerganKDV Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q2 2023, buying an estimated $26K and bringing the position to 13,689 shares worth $1.84M. The position accounts for 0.18% of the portfolio, ranked #94.

BerganKDV Wealth Management first reported a position in ABBV in Q1 2016 and has held it in 30 quarters since. The position peaked at $2.36M in Q3 2019. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • BerganKDV Wealth Management held 13,689 shares of AbbVie worth $1.84M as of Q2 2023.
  • BerganKDV Wealth Management bought 177 AbbVie shares in Q2 2023, an estimated $26K.
  • AbbVie made up 0.18% of BerganKDV Wealth Management's portfolio in Q2 2023, its #94 holding.
  • BerganKDV Wealth Management first reported a position in AbbVie in Q1 2016 and has held it in 30 quarters since.
  • BerganKDV Wealth Management's AbbVie position peaked at $2.36M in Q3 2019.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.